Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Baron Health Care Fund's investment thesis on Cytokinetics, Incorporated ($CYTK) — Q3 2026 | Buyside Digest

All Pitches

View Letter Analysis

$CYTKCytokinetics, Incorporated

BEAR

Baron Health Care Fund

Fund Letter

Q3 2026

Published October 14, 2026

View Fund Profile

$68.78USD

Current Market Price

Market Cap$10.9B

Technical Chart

From the Fund Letter

Cytokinetics, Incorporated ($CYTK) is a biopharmaceutical enterprise focused on muscle biology therapies to treat cardiovascular diseases. The manager took...

— Neal Kaufman

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.

Institutional Pitch Library

Proprietary AI Analysis

100 Letter Unlocks/Quarter

SUBSCRIBE TO BSD RESEARCH Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $CYTK, and what else Baron Health Care Fund is buying.

Other pitches on $CYTK

Other investors who've written on Cytokinetics, Incorporated

No other institutional pitches found for this ticker yet.

View all $CYTK pitches →